We estimated that at least 5–10 million individuals are infected with HTLV-1. Importantly, this
number is based on the study of nearly 1.5 billion people living in known human T-cell …

Despite development of preventive and controlling strategies regarding infectious diseases,
they are still considered as one of the most significant leading causes of morbidity and …

ABSTRACT A method was developed to identify human T-lymphotropic virus-1 (HTLV-1)
using cadmium–tellurium quantum dots. Two probes including the biotin-labeled acceptor …

Adult T cell leukemia/lymphoma (ATLL) is a life-threatening malignancy of HTLV-1 infected
Th lymphocytes. In the present study host–virus interactions were investigated by …

Recruitment of leukocytes by chemokines and chemokine receptors to CNS plays a crucial
role in the induction of inflammatory response in HTLV‐1‐associated myelopathy/tropical …

Aim: This study aimed to investigate the frequency and phylogenetic distribution of human T-
lymphotropic virus type 1 (HTLV-1) in thalassemia cases. Methods: Between 2006 and …

BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) was the first retrovirus
identified in human. The current evidence is quite scarce regarding the potential role of …

Background: Adult T-cell leukemia/lymphoma (ATLL) is caused by human T-cell
lymphotropic virus type-1 (HTLV-1). HTLV-1 oncogenes can induce malignancy through …

Objective (s): Here, a reporter cell line containing two reporter vectors were developed, in
order to monitor the Human T-Lymphotropic Virus type1 (HTLV-1) infectivity and the cell …

Background: Human T-lymphotropic virus type 1 (HTLV-1) infection is a major health
problem that effects a variety of endemic regions, including the Northeast of Iran. There is a …